ISO 13485:2016 certified · Startup India (DPIIT) recognised · NVIDIA Inception program member +91 44 4690 0555info@medoqi.tech
Home/Services/Clinical & Performance Evaluation
CE · Clinical & Performance

Clinical & Performance Evaluation

Generate defensible clinical and performance evidence. Our medical writers, clinicians and evidence specialists plan, author and maintain clinical evaluations for medical devices and performance evaluations for IVDs, across the full lifecycle.

MDR Art. 61 · Annex XIVIVDR Art. 56 · Annex XIIIMEDDEV 2.7/1 rev 4MDCG 2020-5 · 2020-6MDCG 2020-7 · 2020-8MDCG 2022-2ISO 14155:2020ISO 20916:2019
EU MDR · Annex XIV

Medical device clinical evidence

CEP, CER, clinical literature review, equivalence analysis, PMCF, clinical evidence gap assessment and periodic updates, scoped to the device's classification, conformity route and existing evidence.

EU IVDR · Annex XIII

IVD performance evidence

PEP, scientific validity, analytical performance, clinical performance, PER, PMPF and performance evidence updates for Class A to D devices.

How the IVD documents connect →

Shared capabilities: literature methodology, state-of-the-art analysis, benefit–risk, Notified Body query responses. Clinical content is reviewed by medically qualified specialists and PhD scientists. Evidence requirements vary by product, classification, conformity route and available data, so every plan starts from your device.

Clinical evidence gap assessment

A standalone engagement with a fixed scope and a written report.

  • Map existing clinical or performance data against what your class and route require
  • Identify gaps in equivalence, state of the art, PMCF or analytical data
  • Prioritised evidence plan: literature, PMCF, post-market study or investigation
  • Estimated effort and timeline for each option

Clinical evaluation strategy

  • Clinical evaluation strategy matched to device class and risk
  • Clinical evidence gap assessment
  • Equivalence demonstration: technical, biological and clinical
  • State-of-the-art review of alternative treatments and diagnostics
  • Clinical benefit–risk analysis
  • Country-specific feasibility assessment

Literature search & review

  • Search protocols and database-specific search strings
  • Two-stage screening with documented appraisal
  • Data extraction and evidence tables
  • Literature search reports and systematic literature reviews
  • Ongoing literature surveillance for PMS and claims
PubMedEmbaseCochraneCNKI

Clinical documentation for devices

  • Clinical evaluation plans (CEP) and reports (CER), new and updated
  • Clinical development plans
  • Summary of Safety and Clinical Performance (SSCP), including the patient section
  • SOPs and templates for clinical evaluation
  • Responses to Notified Body clinical queries
MDR Art. 32MDCG 2019-9

Performance evaluation for IVDs

  • PEP performance evaluation plan and methodology
  • SVR scientific validity report for the analyte
  • APR analytical performance: sensitivity, specificity, trueness, precision, LoD and measuring range
  • CPR clinical performance report and CPSP study plans
  • PER performance evaluation report and conclusions
  • SSP summary of safety and performance for Class C and D
IVDR Annex XIIIMDCG 2022-2

Global clinical documentation

  • China CER for NMPA, including CNKI searches and Chinese-language appraisal
  • CERs for HAS (France) and Singapore
  • Health Canada summary reports
  • Clinical evidence packages for the TGA
  • Clinical data and reports for Japan, South Korea and India

PMCF & PMPF

  • PMCF plans aligned with the PMS plan and CER
  • Study design, endpoints, acceptance criteria and sample size rationale
  • Validated questionnaires, eCRFs and survey protocols
  • PMCF surveys of healthcare professionals and users
  • Registry and national database studies for long-term follow-up
  • PMCF evaluation reports with benefit–risk updates
MDCG 2020-7MDCG 2020-8

Clinical investigations

  • Study design advisory and endpoint definition
  • Clinical investigation plans and CRF development
  • CRO and site coordination
  • Clinical study reports ready for submission
  • IVD clinical performance studies
  • Retrospective and real-world evidence studies for legacy device gaps
ISO 14155:2020ICH E6 GCPISO 20916

Claims & publications

  • Clinical claims aligned with the available evidence
  • Claims matrix and value messaging by audience
  • Publication planning and target journal selection
  • Manuscript development and journal formatting

Clinical file maintenance

  • Update schedules synchronised with PSUR and PMS cycles
  • Tracking of submission timelines and file versions
  • Cross-functional readiness for planned updates
Literature review methodology

Searches you can reproduce, conclusions you can trace

Reviewers check the method before the conclusions. Every review we run documents each step so it can be repeated and audited.

  1. 01

    Protocol

    Questions, databases, search strings and inclusion criteria, agreed before searching.

  2. 02

    Search

    Documented searches with dates and hit counts in PubMed, Embase, Cochrane and others.

  3. 03

    Screen & appraise

    Two-stage screening with exclusion reasons, and appraisal of each source's suitability and contribution.

  4. 04

    Extract & analyse

    Evidence tables, then analysis against safety, performance and benefit claims.

  5. 05

    Trace & report

    Every conclusion traced to its source, with a PRISMA-style flow and full references.

From evidence plan to review

What you receive

A clinical evaluation report that follows a structure reviewers recognise, with a plan that states how each conclusion will be reached before data is gathered.

  1. 01Evidence planCEP or PEP with scope, methods and acceptance criteria.
  2. 02Data and analysisLiterature, manufacturer data, PMS and PMCF inputs appraised and analysed.
  3. 03Report and medical reviewCER or PER authored, then reviewed by a medically qualified specialist.
  4. 04Notified Body reviewQuery responses prepared and file updated until the review closes.

Typical CER structure · based on MEDDEV 2.7/1 rev 4 Appendix A9, adapted for the MDR

  • Summary
  • Scope of the clinical evaluation
  • Clinical background, current knowledge and state of the art
  • Device under evaluation and type of evaluation
  • Demonstration of equivalence, where claimed
  • Clinical data from the manufacturer and from literature
  • Appraisal and analysis of clinical data against the GSPRs
  • Benefit–risk determination and conclusions
  • PMCF needs and date of the next update
  • Evaluator qualifications and declarations of interest
  • References
Talk to our experts

Discuss your device, market or audit with a specialist

Share the device, its class and your target markets. A senior specialist will come back with the likely pathway, the evidence gaps we see and a practical plan.

Talk to our experts → Request an AI pilot sales@medoqi.tech · +91 44 4690 0555